Twist Bioscience Expands Infectious Disease Product Line Adding Comprehensive Viral Panel

-- Panel Distinguishes Between More than 3,000 Different infectious Diseases -- SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of the Twist Comprehensive Viral Research Panel, a next-generation sequencing (NGS) panel that includes more [...]

Twist Bioscience Continues Support for Next Generation of Synthetic Biologists Through Work with iGEM Competition

- Partners with Ginkgo Bioworks on “Ginkgo Challenge” -- SAN FRANCISCO & CAMBRIDGE, Mass. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced its continued partnership with the International Genetically Engineered Machine (iGEM) Foundation. As a long-time supporter of iGEM, in [...]

PerkinElmer Launches New HPLC, UHPLC and Next Generation Software Solution

LC 300™ platform and SimplicityChrom™ software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance WALTHAM, Mass. --  PerkinElmer, Inc., today introduced the LC 300™ platform and SimplicityChrom™ software, bringing together advanced high-performance liquid chromatography (HPLC) and ultra-high performance liquid chromatography (UHPLC) capabilities with intuitive instrument control and data analysis. The new solution [...]

IDT Continues Support of iGEM to Promote Next Generation of Synthetic Biology Researchers and Leaders

IDT is iGEM Platinum Sponsor for 7th year, providing products, educational content, and mentoring to international participants CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, is continuing its long-time support of the International Genetically Engineered Machine (iGEM) Foundation as a platinum sponsor for the upcoming iGEM 2020 competition. The event [...]

FUJIFILM Cellular Dynamics and Lonza agree to expand the availability and use of induced pluripotent stem cell technology

FUJIFILM Cellular Dynamics grants Lonza a non-exclusive right to use their patents related to iPSC generation, including episomal vectors and reprogramming factors, for development and clinical manufacture of iPSC lines for cell therapies  Lonza grants FUJIFILM Cellular Dynamics expanded use of its non-exclusive license to its innovative NucleofectorTM technology The agreement enables drug developers to [...]

Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs

Indianapolis, Indiana  - Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler, Germany. m2p-labs is best known for its transformative BioLector plate-based microbioreactors, which support automated solutions for screening and bioprocess development. “Innovation defines our future,” said Greg Milosevich, President, Beckman Coulter Life Sciences. “m2p-labs [...]

Qilu Pharmaceutical and ABEC Continue Large-Scale Bioreactor Partnership

ABEC Bioreactor Systems to Support Ongoing Expansion of Qilu’s Biopharmaceutical Production Capacity Bethlehem, PA, USA – ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced Qilu Pharmaceutical Co. has again selected ABEC to rapidly expand production capacity at their cGMP manufacturing facility in Jinan, Shandong, China. ABEC is delivering several sets of [...]

Smiths Detection expands IONSCAN 600 capabilities to detect Spice

Smiths Detection, a leading threat detection and security technology company, announces that it has developed the capability to detect synthetic cannabinoids, commonly known as Spice or K2, with its IONSCAN 600 trace detection solution. This development comes following an extensive R&D process and testing trials with major correctional institutions around the world and expands the IONSCAN [...]

Ovarian Cancer Project Shows Promise

Porvair Sciences reports, due to promising results, it has agreed with its collaborative partners to make additional investment in the CEAT project** which aims to dramatically improve the diagnosis and treatment of ovarian cancer. In the initial stage of the CEAT (Cluster for Epigenomic and Antibody Drug Conjugate Therapeutics) project - Porvair Sciences supplied its [...]

MRC Holland Announces digitalMLPA – A Revolution in Copy Number Variation Detection

digitalMLPA allows for the simultaneous copy number determination of up to 1000 different DNA sequences in one simple reaction. MRC Holland announces the launch of its SALSA® digitalMLPA technology, a novel technique that enables the simultaneous quantification of hundreds of genomic targets. Alterations in the number of gene copies (known as copy number variations, or [...]

Access IBO on Knowledge Center